1. AHRO : Austin Health Research Online

Alexander Dobrovic

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Alexander Dobrovic
Full Name
Dobrovic, Alexander
 
Department
 
ORCID
Twitter
Loading... 3 0 20 0 false

Publications

Refined By:
Fulltext:  No Fulltext

Results 81-88 of 88 (Search time: 0.007 seconds).

Publication YearTitleAuthor(s)
8120-Nov-2014Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors.Chia, Puey Ling ; Mitchell, Paul L R ; Dobrovic, Alexander ; John, Thomas 
821-Oct-2014DNA ligase-based strategy for quantifying heterogeneous DNA methylation without sequencing.Wee, Eugene J H; Rauf, Sakandar; Shiddiky, Muhammad J A; Dobrovic, Alexander ; Trau, Matt
831-May-2014The clinical relevance of pathologic subtypes in metastatic lung adenocarcinoma.Clay, Timothy D; Do, Hongdo; Sundararajan, Vijaya; Moore, Melissa M; Conron, Matthew; Wright, Gavin M; McLachlan, Sue-Anne; Dobrovic, Alexander ; Russell, Prudence A
8430-Apr-2014Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine.Wright, Gavin M; Do, Hongdo; Weiss, Jonathan; Alam, Naveed Z; Rathi, Vivek; Walkiewicz, Marzena; John, Thomas ; Russell, Prudence A; Dobrovic, Alexander 
8526-Feb-2014A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma.Do, Hongdo; Wong, Nicholas C; Murone, Carmel ; John, Thomas ; Solomon, Benjamin J; Mitchell, Paul L R ; Dobrovic, Alexander 
8613-Dec-2013Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours.Wong, Stephen Q; Li, Jason; Sheppard, Karen E; Do, Hongdo; Tothill, Richard W; McArthur, Grant A; Dobrovic, Alexander 
874-Nov-2013BRAF inhibitor-driven tumor proliferation in a KRAS-mutated colon carcinoma is not overcome by MEK1/2 inhibition.Andrews, Miles C; Behren, Andreas; Chionh, Fiona; Mariadason, John M ; Vella, Laura J; Do, Hongdo; Dobrovic, Alexander ; Tebbutt, Niall C ; Cebon, Jonathan S 
8814-Feb-2013Docetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trial.Tebbutt, Niall C ; Parry, M M; Zannino, D; Strickland, A H; Van Hazel, G A; Pavlakis, N; Ganju, V; Mellor, D; Dobrovic, Alexander ; Gebski, V J